{"id":{"repo_id":"mtu","oai_identifier":"oai:digitalcommons.mtu.edu:etdr-2134"},"canonical_url":"https://search.ndltd.org/etd/mtu/oai:digitalcommons.mtu.edu:etdr-2134","repository":{"repo_id":"mtu","name":"Michigan Technological University","base_url":"https://digitalcommons.mtu.edu/do/oai/"},"display":{"title":"Macromolecular strategies for discovering disease-related proteins and new therapeutic agents","abstract":"The existence of every living system depends on the concerted interactions of macromolecules. The major macromolecules include proteins, lipids, carbohydrates and nucleic acids. Numerous other molecules work in collaboration with them to keep the living systems functional. By studying macromolecular interactions, we gain insights into the specific pathways necessary for cellular survival and how these pathways are altered under pathological conditions. In order to study those molecular interactions and the biological processes they drive, one must obtain these (macro)molecules in pure form. Therefore, purification and separation techniques remain at the forefront of biomolecular and biomedical research. This dissertation presents new as well as modified techniques and shows their utility in purifying disease-related proteins and new bioactive compounds with therapeutic potential. The first section of this dissertation describes a new protein purification method, termed Capture and Release (CaRe). This method was developed and validated to alleviate some of the limitations imposed by currently practiced techniques. CaRe uses the multivalent interactions that occur between a protein and its multivalent ligand to rapidly and effectively purify proteins from cell lysates and other crude preparations. CaRe was used to successfully purify three glycan-binding proteins or lectins (Galectin-3, SBA and ConA) and two glycoproteins (Tarin and Ovalbumin). This method does not need elaborate infrastructure and extended operational time that is required by conventional purification methods. CaRe is efficient, favorable even for small sample volumes, and could be a valuable tool for proteomics, glycomics, and glycoproteomics. The second section of this dissertation shows the application of modified conventional separation techniques in the discovery of new bioactive compounds from plant tissues. The new compound is named Hely411, which is a hemolysin with an apparent molecular mass of 2 kDa. It interacts with N-linked glycoproteins and membrane lipids. Hely411 shows the characteristics of a glycoside with a constituent lipid moiety. It disrupts membrane structures before completely rupturing the cells. Hely411 could dissolve blood clots within 5 minutes of incubation and successfully produced RBC ghost cells. Considering all the characteristics, Hely411 could be used as a new therapeutic agent and a reagent for biomedical research.","abstract_html":"The existence of every living system depends on the concerted interactions of macromolecules. The major macromolecules include proteins, lipids, carbohydrates and nucleic acids. Numerous other molecules work in collaboration with them to keep the living systems functional. By studying macromolecular interactions, we gain insights into the specific pathways necessary for cellular survival and how these pathways are altered under pathological conditions. In order to study those molecular interactions and the biological processes they drive, one must obtain these (macro)molecules in pure form. Therefore, purification and separation techniques remain at the forefront of biomolecular and biomedical research. This dissertation presents new as well as modified techniques and shows their utility in purifying disease-related proteins and new bioactive compounds with therapeutic potential. The first section of this dissertation describes a new protein purification method, termed Capture and Release (CaRe). This method was developed and validated to alleviate some of the limitations imposed by currently practiced techniques. CaRe uses the multivalent interactions that occur between a protein and its multivalent ligand to rapidly and effectively purify proteins from cell lysates and other crude preparations. CaRe was used to successfully purify three glycan-binding proteins or lectins (Galectin-3, SBA and ConA) and two glycoproteins (Tarin and Ovalbumin). This method does not need elaborate infrastructure and extended operational time that is required by conventional purification methods. CaRe is efficient, favorable even for small sample volumes, and could be a valuable tool for proteomics, glycomics, and glycoproteomics. The second section of this dissertation shows the application of modified conventional separation techniques in the discovery of new bioactive compounds from plant tissues. The new compound is named Hely411, which is a hemolysin with an apparent molecular mass of 2 kDa. It interacts with N-linked glycoproteins and membrane lipids. Hely411 shows the characteristics of a glycoside with a constituent lipid moiety. It disrupts membrane structures before completely rupturing the cells. Hely411 could dissolve blood clots within 5 minutes of incubation and successfully produced RBC ghost cells. Considering all the characteristics, Hely411 could be used as a new therapeutic agent and a reagent for biomedical research.","abstract_has_math":false,"creators":["Welch, Christina"],"institution":null,"degree_name":"Doctor of Philosophy in Chemistry (PhD)","degree_level":"Campus Access Dissertation","degree_discipline":"Department of Chemistry","degree_department":null,"school":null,"contributors":["Tarun K. Dam"],"advisors":[],"committee_chairs":[],"committee_members":["Lanrong Bi","Qinghui Chen","Shiyue Fang"],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:17:59Z","subjects":["glycoprotein","lectin","glycosaminoglycan","hemolysin","membrane lipid","plant bioactive compounds","plasma membrane","affinity chromatography","hemolysis","hemagglutination","Chemicals and Drugs","Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.mtu.edu/etdr/993"],"render_values":[{"text":"https://digitalcommons.mtu.edu/etdr/993","href":"https://digitalcommons.mtu.edu/etdr/993","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/10.37099/mtu.dc.etdr/993","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/10.37099/mtu.dc.etdr/993","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.mtu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.mtu.edu%3Aetdr-2134","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Tarun K. Dam"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Lanrong Bi","Qinghui Chen","Shiyue Fang"]},{"key":"dc:creator","label":"Author","values":["Welch, Christina"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2021-04-30T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2020-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Department of Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Campus Access Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy in Chemistry (PhD)"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["glycoprotein","lectin","glycosaminoglycan","hemolysin","membrane lipid","plant bioactive compounds","plasma membrane","affinity chromatography","hemolysis","hemagglutination","Chemicals and Drugs","Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.37099/mtu.dc.etdr/993","https://digitalcommons.mtu.edu/etdr/993"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The existence of every living system depends on the concerted interactions of macromolecules. The major macromolecules include proteins, lipids, carbohydrates and nucleic acids. Numerous other molecules work in collaboration with them to keep the living systems functional. By studying macromolecular interactions, we gain insights into the specific pathways necessary for cellular survival and how these pathways are altered under pathological conditions. In order to study those molecular interactions and the biological processes they drive, one must obtain these (macro)molecules in pure form. Therefore, purification and separation techniques remain at the forefront of biomolecular and biomedical research. This dissertation presents new as well as modified techniques and shows their utility in purifying disease-related proteins and new bioactive compounds with therapeutic potential. The first section of this dissertation describes a new protein purification method, termed Capture and Release (CaRe). This method was developed and validated to alleviate some of the limitations imposed by currently practiced techniques. CaRe uses the multivalent interactions that occur between a protein and its multivalent ligand to rapidly and effectively purify proteins from cell lysates and other crude preparations. CaRe was used to successfully purify three glycan-binding proteins or lectins (Galectin-3, SBA and ConA) and two glycoproteins (Tarin and Ovalbumin). This method does not need elaborate infrastructure and extended operational time that is required by conventional purification methods. CaRe is efficient, favorable even for small sample volumes, and could be a valuable tool for proteomics, glycomics, and glycoproteomics. The second section of this dissertation shows the application of modified conventional separation techniques in the discovery of new bioactive compounds from plant tissues. The new compound is named Hely411, which is a hemolysin with an apparent molecular mass of 2 kDa. It interacts with N-linked glycoproteins and membrane lipids. Hely411 shows the characteristics of a glycoside with a constituent lipid moiety. It disrupts membrane structures before completely rupturing the cells. Hely411 could dissolve blood clots within 5 minutes of incubation and successfully produced RBC ghost cells. Considering all the characteristics, Hely411 could be used as a new therapeutic agent and a reagent for biomedical research."]},{"key":"dc:title","label":"Title","values":["Macromolecular strategies for discovering disease-related proteins and new therapeutic agents"]}]}],"canonical_facts":{"dc:contributor":["Tarun K. Dam"],"dc:contributor.committeemember":["Lanrong Bi","Qinghui Chen","Shiyue Fang"],"dc:creator":["Welch, Christina"],"dc:date.available":["2021-04-30T07:00:00Z"],"dc:date.created":["2020-01-01T08:00:00Z"],"dc:description.abstract":["The existence of every living system depends on the concerted interactions of macromolecules. The major macromolecules include proteins, lipids, carbohydrates and nucleic acids. Numerous other molecules work in collaboration with them to keep the living systems functional. By studying macromolecular interactions, we gain insights into the specific pathways necessary for cellular survival and how these pathways are altered under pathological conditions. In order to study those molecular interactions and the biological processes they drive, one must obtain these (macro)molecules in pure form. Therefore, purification and separation techniques remain at the forefront of biomolecular and biomedical research. This dissertation presents new as well as modified techniques and shows their utility in purifying disease-related proteins and new bioactive compounds with therapeutic potential. The first section of this dissertation describes a new protein purification method, termed Capture and Release (CaRe). This method was developed and validated to alleviate some of the limitations imposed by currently practiced techniques. CaRe uses the multivalent interactions that occur between a protein and its multivalent ligand to rapidly and effectively purify proteins from cell lysates and other crude preparations. CaRe was used to successfully purify three glycan-binding proteins or lectins (Galectin-3, SBA and ConA) and two glycoproteins (Tarin and Ovalbumin). This method does not need elaborate infrastructure and extended operational time that is required by conventional purification methods. CaRe is efficient, favorable even for small sample volumes, and could be a valuable tool for proteomics, glycomics, and glycoproteomics. The second section of this dissertation shows the application of modified conventional separation techniques in the discovery of new bioactive compounds from plant tissues. The new compound is named Hely411, which is a hemolysin with an apparent molecular mass of 2 kDa. It interacts with N-linked glycoproteins and membrane lipids. Hely411 shows the characteristics of a glycoside with a constituent lipid moiety. It disrupts membrane structures before completely rupturing the cells. Hely411 could dissolve blood clots within 5 minutes of incubation and successfully produced RBC ghost cells. Considering all the characteristics, Hely411 could be used as a new therapeutic agent and a reagent for biomedical research."],"dc:identifier":["10.37099/mtu.dc.etdr/993","https://digitalcommons.mtu.edu/etdr/993"],"dc:subject":["glycoprotein","lectin","glycosaminoglycan","hemolysin","membrane lipid","plant bioactive compounds","plasma membrane","affinity chromatography","hemolysis","hemagglutination","Chemicals and Drugs","Medicine and Health Sciences"],"dc:title":["Macromolecular strategies for discovering disease-related proteins and new therapeutic agents"],"thesis:degree_discipline":["Department of Chemistry"],"thesis:degree_level":["Campus Access Dissertation"],"thesis:degree_name":["Doctor of Philosophy in Chemistry (PhD)"]},"updated_at":"2026-11-19T08:17:59Z"}